NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00451048 2018-09-04Sunitinib in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Completed10 enrolled 9 charts
NCT00387426 2014-05-28Sunitinib in Treating Patients With Idiopathic MyelofibrosisNational Cancer Institute (NCI)Phase 2 Terminated14 enrolled 5 charts
NCT00890747 2014-03-17Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNational Cancer Institute (NCI)Phase 1 Completed42 enrolled